In summary, this study has shed light on the importance of the role of inflammatory biomarkers as KL-6 in diagnosis of hypersensitivity pneumonitis and consequently the monitoring of therapeutic effect of the used medications for the treatment of HP. The gene discussed is MUC1; the disease is hypersensitivity pneumonitis.